Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Athens Medical CentreFRA:ACS 25 3-1 Month Momentum % is -0.61% as of Aug. 09, 2026. GuruFocus rates FRA:ACS with a GF Score™ of 25/100 and a GF Value™ of €1.73 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 674 Healthcare Providers & Services companies, Athens Medical Centre ranks better than 61.28% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-09), Athens Medical Centre's 3-1 Month Momentum % is -0.61%.
The industry rank for Athens Medical Centre's 3-1 Month Momentum % or its related term are showing as below:
FRA:ACS's 3-1 Month Momentum % is ranked better than 61.28% of 674
companies
in the Healthcare Providers & Services industry
Industry Median: -2.945
vs FRA:ACS: -0.61
Athens Medical Centre (FRA:ACS) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Athens Medical Centre 3-1 Month Momentum % Related Terms
FRA:ACS vs HCA, THC, DVA: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Athens Medical Centre's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Athens Medical Centre 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Athens Medical Centre's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Athens Medical Centre's 3-1 Month Momentum % falls into.
Athens Medical Centre (FRA:ACS) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Athens Medical Centre (FRA:ACS) has a 3-1 Month Momentum % of -0.61% as of Aug. 09, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Athens Medical Centre and its competitors. According to the industry distribution chart, Athens Medical Centre ranks #261 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 38.7%.
Is Athens Medical Centre's 3-1 Month Momentum % too high?
Athens Medical Centre's current 3-1 Month Momentum % is -0.61%. Based on the distribution chart, Athens Medical Centre ranks #261 out of 674 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Athens Medical Centre has a GF Score™ of 25/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's 3-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Athens Medical Centre ranks #261 out of 674 companies for 3-1 Month Momentum %. This puts Athens Medical Centre in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Athens Medical Centre and its competitors. Athens Medical Centre's current 3-1 Month Momentum % is -0.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Based on GuruFocus' analysis, Athens Medical Centre (FRA:ACS) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.73, compared to a current price of €1.49 — trading 13.9% below its estimated fair value. The current 3-1 Month Momentum % is -0.61%. Athens Medical Centre's overall GF Score™ is 25/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Athens Medical Centre (FRA:ACS), the current 3-1 Month Momentum % is -0.61% as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Athens Medical Centre (FRA:ACS) Overvalued in 2026?
Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued.
The current stock price of €1.49 is trading 13.9% below its estimated GF Value™ of €1.73.
GuruFocus considers Athens Medical Centre to be Modestly Undervalued.
Key valuation signals for FRA:ACS:
3-1 Month Momentum %: -0.61%
GF Value™: €1.73 vs. price of €1.49 (13.9% below fair value)
No single metric tells the full story. See the FRA:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
25GF Score
Get the complete analysis for FRA:ACS
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ACS has been successfully added to your 
